[Federal Register Volume 86, Number 124 (Thursday, July 1, 2021)]
[Notices]
[Page 35094]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14008]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee 
(HICPAC) Meeting

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Healthcare Infection Control 
Practices Advisory Committee (HICPAC). This virtual meeting is open to 
the public, limited only by audio and web conference lines (300 audio 
and web conference lines are available). Registration is required. To 
register for this web conference, please go to: www.cdc.gov/hicpac. All 
registered participants will receive the meeting link and instructions 
shortly before the meeting.

DATES: The meeting will be held on August 19, 2021, from 12:00 p.m. to 
2:00 p.m., EDT.

ADDRESSES: Please click the link below to join the webinar: https://cdc.zoomgov.com/j/1612908106?pwd=M0xTVWxmUTRtZXhuOVBzWmsybFZxZz09.
Meeting ID: 161 290 8106
Passcode: yq!BLL44
Dial-in Lines:
    +1-669-254-5252 (San Jose)
    +1-646-828-7666 (New York)
Meeting ID: 161 290 8106
Telephone Passcode: 47632330.

FOR FURTHER INFORMATION CONTACT: Koo-Whang Chung, M.P.H., HICPAC, 
Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton 
Road NE, Mailstop H16-3, Atlanta, Georgia 30329-4027; Telephone: (404) 
498-0730; Email: [email protected].

SUPPLEMENTARY INFORMATION:
    Purpose: The Committee is charged with providing advice and 
guidance to the Director, Division of Healthcare Quality Promotion 
(DHQP), the Director, National Center for Emerging and Zoonotic 
Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health 
and Human Services regarding (1) the practice of healthcare infection 
prevention and control; (2) strategies for surveillance, prevention, 
and control of infections, antimicrobial resistance, and related events 
in settings where healthcare is provided; and (3) periodic updating of 
CDC guidelines and other policy statements regarding prevention of 
healthcare-associated infections and healthcare-related conditions.
    Matters To Be Considered: The agenda will include the following 
updates: The Healthcare Personnel Guideline Workgroup; the Isolation 
Precautions Guideline Workgroup; and the Neonatal Intensive Care Unit 
Workgroup. Agenda items are subject to change as priorities dictate.
    Procedures for Public Comment: Time will be available for public 
comment. Members of the public who wish to provide public comments 
should plan to attend the public comment session at the start time 
listed. Please note that the public comment period may end before the 
time indicated, following the last call for comments.
    Procedures for Written Comment: The public may submit written 
comments in advance of the meeting. Comments should be submitted in 
writing by email to the contact person listed above. The deadline for 
receipt of written public comment is July 26, 2021. All requests must 
contain the name, address, and organizational affiliation of the 
speaker, as well as the topic being addressed. Written comments should 
not exceed one single-spaced typed page in length. Written comments 
received in advance of the meeting will be included in the official 
record of the meeting.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-14008 Filed 6-30-21; 8:45 am]
BILLING CODE 4163-18-P